Nantahala Capital Management, LLC An2 Therapeutics, Inc. Transaction History

Nantahala Capital Management, LLC

  • $1.68 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$2.78 - $21.53 $416,999 - $3.23 Million
-150,000 Reduced 60.42%
98,278 $319,000
Q4 2023

Feb 14, 2024
SELL
$13.92 - $21.0 $1.51 Million - $2.28 Million
-108,511 Reduced 30.41%
248,278 $5.09 Million
Q3 2023

Nov 14, 2023
BUY
$7.58 - $16.08 $2.7 Million - $5.74 Million
356,789 New
356,789 $5.74 Million

Others Institutions Holding ANTX

# of Institutions
33
Shares Held
13.5M
Call Options Held
0
Put Options Held
0
View Full List

About AN2 Therapeutics, Inc.

ANTX Quotes by TradingView
  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $26M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email